top of page


  • SBPL-0600 is an ONCOLYTIC virus therapy which may be effective against Lung, Breast & Prostate cancers.

  • DNA composition (SBPL-0610) that produce SBPL-0600 in situ also produce its therapeutic effect.

  • The efficacy of this DNA composition can be easily modified by incorporating additional plasmids coding for therapeutic genes &/or tumor antigens

  • This phenomenon will be useful for PERSONALIZING CANCER THERAPY based on the specific genetic defects/lesions observed in a given patient

AV Pipeline.png
R & D Pipeline: Services
bottom of page